We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$400B
AUM Growth
-$75.9B
Cap. Flow
+$5.4B
Cap. Flow %
1.35%
Top 10 Hldgs %
18.01%
Holding
6,980
New
409
Increased
2,564
Reduced
2,532
Closed
542

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Healthcare 9.3%
3 Financials 8.52%
4 Consumer Discretionary 7.65%
5 Industrials 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCYC
3751
Bicycle Therapeutics
BCYC
$293M
$2.59M ﹤0.01%
154,326
-8,939
-5% -$189K
COST icon
3752
CALL
Costco
COST
$419B
$2.59M ﹤0.01%
5,400
-47,500
-90% -$24.1M
UVV icon
3753
Universal Corp
UVV
$1.26B
$2.59M ﹤0.01%
42,774
-8,859
-17% -$528K
NRAC
3754
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$2.58M ﹤0.01%
262,694
AVAN
3755
DELISTED
Avanti Acquisition Corp.
AVAN
$2.58M ﹤0.01%
260,183
+14,090
+6% +$139K
INO icon
3756
Inovio Pharmaceuticals
INO
$67.4M
$2.58M ﹤0.01%
124,072
+46,299
+60% +$1.3M
THAC
3757
DELISTED
Thrive Acquisition Corporation Class A ordinary shares
THAC
$2.56M ﹤0.01%
255,327
PMGM
3758
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$2.56M ﹤0.01%
258,063
AHCO icon
3759
AdaptHealth
AHCO
$778M
$2.56M ﹤0.01%
141,831
-864
-0.6% -$14K
LVAC
3760
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
$2.56M ﹤0.01%
256,887
SABR icon
3761
CALL
Sabre
SABR
$810M
$2.56M ﹤0.01%
438,400
+427,800
+4,036% +$3.57M
CRF
3762
Cornerstone Total Return Fund
CRF
$1.17B
$2.55M ﹤0.01%
+312,582
New +$3.2M
CPNG icon
3763
CALL
Coupang
CPNG
$29.5B
$2.55M ﹤0.01%
200,000
+50,000
+33% +$682K
SRG
3764
Seritage Growth Properties
SRG
$136M
$2.55M ﹤0.01%
489,325
-7,947
-2% -$70.9K
BSX icon
3765
PUT
Boston Scientific
BSX
$71.3B
$2.55M ﹤0.01%
68,400
+14,800
+28% +$602K
CASS icon
3766
Cass Information Systems
CASS
$743M
$2.55M ﹤0.01%
75,440
+55,544
+279% +$1.99M
FFIC
3767
DELISTED
Flushing Financial
FFIC
$2.55M ﹤0.01%
119,797
+12,096
+11% +$265K
XSLV icon
3768
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
$2.55M ﹤0.01%
57,205
+39,066
+215% +$1.79M
SRLP
3769
DELISTED
SPRAGUE RESOURCES LP
SRLP
$2.54M ﹤0.01%
+133,853
New +$2.28M
ZM icon
3770
PUT
Zoom
ZM
$30.5B
$2.54M ﹤0.01%
23,500
-182,900
-89% -$19.3M
SSAA
3771
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
$2.54M ﹤0.01%
258,477
BSM icon
3772
Black Stone Minerals
BSM
$2.99B
$2.53M ﹤0.01%
184,893
+18,979
+11% +$288K
PPYA
3773
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$2.53M ﹤0.01%
253,340
RMR icon
3774
The RMR Group
RMR
$331M
$2.52M ﹤0.01%
88,902
+7,852
+10% +$226K
CODI icon
3775
Compass Diversified
CODI
$834M
$2.51M ﹤0.01%
117,258
-20,297
-15% -$462K

Similar funds

Goldman Sachs's Q2 2022 Portfolio in Review

As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs's Q2 2022 filing shows 409 new, 2,564 increased, 2,532 reduced and 542 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
  • Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
  • Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
  • Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
  • Goldman Sachs opened 409 new positions and closed 542 in Q2 2022.
  • Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.